Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 63
|
ECE2019
|
Next issue
21st European Congress of Endocrinology
Lyon,
France
18 May 2019 - 21 May 2019
All volumes
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
18-21 May 2019, Lyon, France
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
21th European Congress of Endocrinology 2019
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
New approaches in the differential diagnosis of Diabetes insipidus
ea0063eje1
EJE Award 2019 - Biography
ea0063eje1biog
The Geoffrey Harris Prize Lecture
Translational research in pituitary disease
ea0063gh1
ESE Geoffrey Harris Prize 2019 - Biography
ea0063gh1biog
European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
ea0063ehm1
European Hormone Medal 2019 - Biography
ea0063ehm1biog
Clinical Endocrinology Trust Lecture
How can patients' perception of outcome be improved after controlling pituitary disease?
ea0063cet1
Clinical Endocrinology Trust Award 2019 - Biography
ea0063cet1biog
Plenary Lectures
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
ea0063pl1
Genetic epidemiology of puberty timing and reproductive lifespan (Endorsed by the European Journal of Endocrinology)
Genetic epidemiology of puberty timing and reproductive lifespan
ea0063pl2
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
ea0063pl3
Exercise Training in the Management of Type 2 Diabetes
Exercise Training in the Management of Type 2 Diabetes
ea0063pl4
Paracrine regulation of the adrenal cortex
Paracrine regulation of the adrenal cortex
ea0063pl5
Graves orbitopathy
Graves Orbitopathy
ea0063pl6
Control of Integrative Physiology by the Melanocortin Circuitry
Control of Integrative Physiology by the Melanocortin Circuitry
ea0063pl7
Symposia
Thyroid in cancer
What is the value of molecular markers in nodules?
ea0063s1.1
Iodine refractoriness in thyroid cells
ea0063s1.2
New paradigms in the treatment of low risk thyroid cancer
ea0063s1.3
Trends in puberty
Exploring the Epigenetic landscape of puberty
ea0063s2.1
Endocrine disrupters in puberty
ea0063s2.2
The genetic basis of pubertal timing
ea0063s2.3
Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
ea0063s3.1
Fixing the broken clock in adrenal disorders
ea0063s3.2
Understanding the molecular basis of seasonal changes in behavior
ea0063s3.3
Immunology and endocrinology (Endorsed by Endocrine Connections)
Basic: immunotherapy and endocrine disease
ea0063s4.1
Clinical: Immunotherapy and endocrine disease
ea0063s4.2
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
ea0063s4.3
Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
ea0063s5.1
Fecal transplantation: Myth or reality
ea0063s5.2
Targeted Microbiome Intervention for handling insulin resistance
ea0063s5.3
A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology)
Prediction of the thyroid axis set-point
ea0063s6.1
Subclinical hypothyroidism in children
ea0063s6.2
Subclinical hypothyroidism in the elderly
ea0063s6.3
Endocrine disrupting chemicals (Endorsed by Endocrine Connections)
Mixtures measured in human, disrupt thyroid hormone signaling and behavior in Xenopus laevis
ea0063s7.1
Actions of endocrine disrupting chemicals on pancreatic beta cells and risk of diabetes mellitus
ea0063s7.2
Prenatal obesogen exposure leads to a transgenerational thrifty phenotype in mice
ea0063s7.3
Genderdysphoria - delayed puberty
Psychoendocrinology of gender dysphoria
ea0063s8.1
Management of puberty in transgender adolescents
ea0063s8.2
Gender reassignment surgery in dysphoria
ea0063s8.3
Controversies in adrenal disease
Metanephrines: Plasma or Urine
ea0063s9.1
The dos and don'ts of genetic testing in phaeochromocytoma
ea0063s9.2
Is there a role for subtotal adrenalectomy
ea0063s9.3
Cancer drug-induced osteoporosis (Endorsed by Endocrine Connections)
Mechanisms of skeletal metastasis
ea0063s10.1
Aromatase inhibitors and bone
ea0063s10.2
TSH suppressive therapy and bone
ea0063s10.3
EDCs & reproduction
Impact of pesticide postnatal exposure on oocyte quality and clinical outcomes of patient undergoing IVf programme
ea0063s11.1
Environmental endocrine disruptors and testicular germ cell cancer
ea0063s11.2
Mitigating against endocrine disruption in pregnancy
ea0063s11.3
Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
ea0063s12.1
New potential treatment alternatives in patients with papillary craniopharyngioma
ea0063s12.2
How to manage the long-term consequences of hypothalamic damages
ea0063s12.3
Central control of metabolism: Brain rules all
Sensors of survival: Pleiotropic function and the regulation of hunger circuits
ea0063s13.1
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
ea0063s13.2
Genetics of appetite regulation: Can an old dog teach us new tricks?
ea0063s13.3
Innovations in NETs
Innovative imaging of benign insulinomas - the end of sampling
ea0063s14.1
A role for radionuclide therapy for high-grade NETs
ea0063s14.2
Fishing for NETs
ea0063s14.3
European Young Endocrine Scientists (EYES)
European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
ea0063s15.1
Investigating glucocorticoid excess as mediators of bone marrow adiposity expansion during caloric restriction
ea0063s15.2
Best young abstract submission
ea0063s15.3
The role and cross-talk between incretin hormones and occurrence of non-alcoholic steatohepatitis
ea0063s15.4
Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
ea0063s15.5
Closing remarks and invitation to the EYES social
ea0063s15.6
Thyroid in pregnancy
Thyroid autoimmunity and (in)fertility
ea0063s16.1
Thyroid disease and pregnancy outcomes
ea0063s16.2
Mild maternal thyroid dysfunction during pregnancy and offspring neurodevelopment
ea0063s16.3
Where do pituitary tumours come from?
Specification of pituitary cell fates
ea0063s17.1
Pertubations in novel signalling pathways
ea0063s17.2
'From Lab to Clinic - Can we translate into effective therapeutics'
ea0063s17.3
Congenital hypogonadotropic hypogonadism: New insights into GnRH Regulation
The transcription factor Gli3 plays a pivotal role in controlling the development of the terminal nerve and GnRH-1 neuronal migration
ea0063s18.1
Flipping the GnRH switch with microRNAs
ea0063s18.2
Congenital hypogonadotropic hypogonadism: clinical perspectives
ea0063s18.3
Adrenal insufficiency
New insights into autoimmune adrenal insuffisiency
ea0063s19.1
Long-term results of modified release glucocorticoids in adrenal insufficiency - are they really better?
ea0063s19.2
Optimising care delivery in congenital adrenal hyperplasia
ea0063s19.3
News on nutrition: when to eat what
Precision nutrition for managing obesity - does it work?
ea0063s20.1
Is limiting the timing of food intake a viable nutritional approach?
ea0063s20.2
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
ea0063s20.3
Rare bone disorders
Animal models of bone fragility
ea0063s21.1
New perspectives on the treatment of skeletal dysplasia
ea0063s21.2
Osteogenesis imperfecta throughout life
ea0063s21.3
The pituitary as metabolic sensor (Endorsed by Endocrine Connections)
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
ea0063s22.1
How treatments with endocrine & metabolic drugs influence pituitary cell function?
ea0063s22.2
Bidirectional interrelationship between growth hormone and metabolism
ea0063s22.3
PCOS: can we personalise treatment?
Gut and brain axis
ea0063s23.1
Implicating androgen excess in metabolic disease in PCOS
ea0063s23.2
Treatment options in cardiometabolic pcos phenotype
ea0063s23.3
What's new in the Adrenal Cortex? (Endorsed by the European Journal of Endocrinology)
Adrenocortical tumors: new genes, new understanding, new therapy
ea0063s24.1
Primary hyperaldosteronism: does our treatment work?
ea0063s24.2
Autonomous cortisol secretion has cardiovascular consequences
ea0063s24.3
Late Breaking Session
Liver Stress kinases - crossroad between obesity and liver cancer (Source paper: Nature 2019)
ea0063s25.1
Levothyroxine in preconception women with thyroid peroxidase antibodies
ea0063s25.2
Maternal smoking and high BMI disrupt thyroid gland development
ea0063s25.3
Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
ea0063s26.1
Bone
ea0063s26.2
Thyroid hormones in the cardiac physiopathology
ea0063s26.3
What's new in reproductive endocrinology?
Dissecting androgens in Polycystic Ovary Syndrome (PCOS)
ea0063s27.1
Large scale genetic studies in male infertility
ea0063s27.2
Menopause and cardiovascular risk
ea0063s27.3
Vitamin D - non-skeletal effects in RCT
Vitamin D for healthy ageing
ea0063s28.1
Vitamin D and type 1 diabetes
ea0063s28.2
How and when to measure vitamin D?
ea0063s28.3
Endocrine controversies in sport
Female hyperandrogenism and elite sport
ea0063s29.1
Performance enhancing drugs in young males
ea0063s29.2
Omics to fight doping
ea0063s29.3
Personalised medicine in diabetes and obesity (Endorsed by the European Journal of Endocrinology)
Mechanisms for Cardiovascular Complications of Diabetes - Implications for Personalized Therapy
ea0063s30.1
New avenues for novel drugs to treat obesity
ea0063s30.2
Curing diabetes with alternatives: bariatric surgery
ea0063s30.3
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - Endocrinology of Aging
Obesity gives you cancer: the bigger picture!
ea0063ss1.1
Sleep deficiency: A pathway to obesity
ea0063ss1.2
Obesity is an economic burden and we know why
ea0063ss1.3
New Scientific Approaches
(1)
Steroidomics
ea0063nsa1
Single cell spatial reconstruction of endocrine organs
ea0063nsa2
Intelligent image based in situ single cell isolation
ea0063nsa3
How can AI create value for the endocrinologist? Challenges and opportunities for AI-enabled solutions
ea0063nsa4
Genome-wide effects of vitamin D on chromatin
ea0063nsa5
Diving into the brain: deep brain imaging techniques in conscious animals.
ea0063nsa6
Debates
Food addiction in humans: to be or not to be?
PRO: Food addiction in humans: to be or not to be?
ea0063d1.1
CON: Food addiction in humans: to be or not to be?
ea0063d1.2
Surgical treatment of phaeochromocytoma - query pre-treatment
PRO: Surgical treatment of phaeochromocytoma - query pre-treatment?
ea0063d2.1
CON: Surgical treatment of phaeochromocytoma - query pre-treatment?
ea0063d2.2
T4 is not enough
'Yes, T4 is not enough'
ea0063d3.1
'No, T4 is enough'
ea0063d3.2
Pituitary pathology: Do we care?
Yes, we care about pituitary pathology!
ea0063d4.1
No, we don't care about pituitary pathology
ea0063d4.2
MicroRNAs as hormones?
PRO: MicroRNAs and extracellular vesicles as hormones?
ea0063d5.1
CON: MicroRNAs and extracellular vesicles as hormones?
ea0063d5.2
Should we treat young osteoporotic patients?
Yes, we should treat young osteoporotic patients
ea0063d6.1
'No, we shouldn't treat young osteoporotic patients'
ea0063d6.2
Meet the Expert Sessions
(1)
The road from flash glucose monitoring to hybrid closed loop systems: keys to success.
ea0063mte1
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
ea0063mte2
The management of primary aldosteronism
ea0063mte3
Management of a life-long disease in CAH
ea0063mte4
Risk classification of thyroid nodules by ultrasound and indications for FNA
ea0063mte5
Primary Hyperparathyroidism: Surgical vs. Medical Therapy
ea0063mte6
Non functional Pituitary Tumours - not always easy
ea0063mte7
Comorbidities in Turner Syndrome
ea0063mte8
Co-morbidities in Klinefelter syndrome
ea0063mte9
NCAH and Female Reproduction
ea0063mte10
'Shifting treatment paradigms in osteoporosis'.
ea0063mte11
Fracture Risk Prediction in Benign and Tumoral Bone: New Insights
ea0063mte12
Flushing, blushing and sweating
ea0063mte13
How multidisciplinay care and tailor-made transition save lives of young adults with Prader-Willi syndrome
ea0063mte14
To what degree does hypopituitarism exist after TBI?
ea0063mte15
Is it all in your head or just in the lab?
ea0063mte16
The metabolic effects of SGLT2 inhibitors - Does the increase in ketone bodies protect the heart?
ea0063eyijc1
Meet the Basic Scientist Session
(1)
New tracers for PET in humans: Hopes, aims and current evidence
ea0063mtbs1
Genetically tailored pig models in translational endocrine and metabolic research
ea0063mtbs2
The gravitostat - possible relation to hormones
ea0063mtbs3
Nurse Sessions
(1)
Overview of immunotherapy: Indications and adverse effects
ea0063ns1.1
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
ea0063ns1.2
The role of the endocrine nurse in managing patients with immunotherapy-induced endocrinopathies
ea0063ns1.3
Nursing approach to the holistic care of patients with intellectual disability
ea0063mtne1
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
ea0063npd1
Testosterone replacement: 'The best practice'.
ea0063npd2
Hypoparathyroidism: Aetiology, diagnosis and challenges in management
ea0063npd2.1
How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
ea0063npd3
MY DIABBY - Improving skills and competence in diabetes education
ea0063npd4
How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
ea0063npd5
Uems Session
(1)
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
ea0063uems1.1
Update on European Exam in Endocrinology
ea0063uems1.2
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
ea0063uems1.3
Oral Communications
Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
ea0063oc1.1
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
ea0063oc1.2
Menin and EZH2 activities modulate the expression of the long non-coding RNA HAR1B in parathyroid tumors
ea0063oc1.3
Risk of sepsis, respiratory infections, and kidney or other genitourinary (GU) infections in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study
ea0063oc1.4
Renal function in 711 patients with hypoparathyroidism during more than 4 years of therapy
ea0063oc1.5
Diabetes 1
Every fifth patient with type 1 diabetes suffers from an additional endocrinological autoimmune disease - a finnish nationwide study
ea0063oc2.1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
ea0063oc2.2
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
ea0063oc2.3
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
ea0063oc2.4
5[beta]-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
ea0063oc2.5
Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
ea0063oc3.1
Outcomes after primary treatment for Nelson's syndrome: a study from 13 UK centres
ea0063oc3.2
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
ea0063oc3.3
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
ea0063oc3.4
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
ea0063oc3.5
Thyroid 1
Subclinical hypothyroidism troughout pregnancy in TPOAb positive pregnant women
ea0063oc4.1
Thyroid dysfunction and mortality in cardiovascular hospitalized patients - a 12 year follow-up observational study
ea0063oc4.2
Prognostic impact of microscopic extrathyroidal extension (mETE) on recurrence-free survival in patients with papillary thyroid carcinoma (PTC)
ea0063oc4.3
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
ea0063oc4.4
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
ea0063oc4.5
Adrenal 1
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
ea0063oc5.1
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
ea0063oc5.2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
ea0063oc5.3
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
ea0063oc5.4
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
ea0063oc5.5
Obesity
Impaired glucose homeostasis in leptin-deficient ob/ob mice is corrected by AZP-3404, a 9-amino acid peptide analog derived from insulin-like growth factor-binding protein 2, a key mediator of leptin action
ea0063oc6.1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
ea0063oc6.2
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
ea0063oc6.3
Fat mass impact of sirolimus after clinical islet transplantation, a case control study
ea0063oc6.4
Lipolysis defect in white adipose tissue and rapid weight regaining
ea0063oc6.5
Endocrine Connections 1
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
ea0063oc7.1
Thyroid hormones are new key regulators of glucocorticoid metabolism
ea0063oc7.2
Higher dose of burosumab is needed for treatment of children with sever forms of X-linked hypophosphatemia
ea0063oc7.3
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA
ea0063oc7.4
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome: French prospective study in a cohort of 25 patients
ea0063oc7.5
Reproduction 1
Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
ea0063oc8.1
AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
ea0063oc8.2
Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus
ea0063oc8.3
Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH neurons reveals specific roles in reproductive and metabolic homeostasis
ea0063oc8.4
The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: responder analysis results from a randomized, placebo-controlled, double-blind, dose-ranging study
ea0063oc8.5
Thyroid 2
3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
ea0063oc9.1
Direct evidence for disulfides in the mechanism of deiodinase 1
ea0063oc9.2
Novel driver mutations in thyroid cancer recurrence
ea0063oc9.3
Resistance to thyroid hormone alpha associated with early-onset severe NASH
ea0063oc9.4
Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models
ea0063oc9.5
Adrenal 2
Steroid metabolomics: a rapid computational approach for accurate differentiation of inborn disorders of steroidogenesis
ea0063oc10.1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
ea0063oc10.2
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (glucocorticoid receptor) and PDE11A4 (phosphodiesterase 11) in 389 patients
ea0063oc10.3
Cullin 3 is a partner of armadillo repeat containing 5 (ARMC5), the product of the gene responsible for primary bilateral macronodular adrenal hyperplasia
ea0063oc10.4
Cyclin dependent kinase 4 as promising drug target in adrenocortical carcinoma
ea0063oc10.5
Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
ea0063oc11.1
Molecular mechanisms regulating hepatic sex hormone-binding globulin production: clinical implications in human diseases
ea0063oc11.2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
ea0063oc11.3
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
ea0063oc11.4
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
ea0063oc11.5
Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
ea0063oc12.1
Epigenetic programming of transgenerational hypertension in preterm birth mice
ea0063oc12.2
Neuronostatin and GPR107 system: a novel therapeutic circuit in prostate cancer
ea0063oc12.3
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
ea0063oc12.4
Sexual desire in transgender persons in relation with gender affirming hormone treatment: Results from ENIGI, a large multicenter prospective cohort study in transgender people
ea0063oc12.5
Anterior and Posterior pituitary 2
Arginine-stimulated copeptin measurements - a new test for diabetes insipidus
ea0063oc13.1
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion - a randomized, double-blind, placebo-controlled trial
ea0063oc13.2
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
ea0063oc13.3
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
ea0063oc13.4
Pan-genomic classification of pituitary adenomas
ea0063oc13.5
Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
ea0063oc14.1
The effect of testosterone therapy on serum oestradiol levels in transgender men
ea0063oc14.2
First identification of bone morphogenic protein receptor variants as a cause of primary ovarian insufficiency
ea0063oc14.3
Thyroid diseases in danish women with polycystic ovary syndrome
ea0063oc14.4
The pattern of cancer occurrence in Turner syndrome
ea0063oc14.5
Guided Posters
Adrenal and Neuroendocrine - Tumour
68Ga-exendin-4 PET/CT detects insulinomas in patients with hypoglycemia in multiple endocrine neoplasia type 1
ea0063gp1
Lanreotide therapy vs wait-and-see in patients with pancreatic neuroendocrine tumors
ea0063gp2
ProGRP is an effective marker for disease monitoring in lung carcinoids with non-informative chromogranin A: Lessons from clinical practice
ea0063gp3
Two cases of pseudopheochromocytoma due to Obstructive sleep apnea: which mechanisms?
ea0063gp4
Pheochromocytoma's of MENX rats belong to the pseudo-hypoxia cluster
ea0063gp5
Cellular modelling of SDH-associated pathomechanism of pheochromocytomas and paragangliomas
ea0063gp6
Parafibromin is regulated by ubiquitin specific protease 37 (USP37) and the c-terminus of USP37 interacts with the beta-catenin binding region of CDC73 in hyperparathyroidism-jaw tumor syndrome
ea0063gp7
Pheochromocytoma: Positive predictive values of mildly-elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients
ea0063gp8
IGF-1 splice variants' expression in adrenal gland neoplasms- Possible role in adrenal tumorigenesis
ea0063gp9
Brown fat proliferation- A rare complication of Phaeochromocytoma
ea0063gp10
Corticotropinoma as the underlying cause of intermittent Cushing's syndrome in a patient previously diagnosed with primary pigmented adrenocortical disease (PPNAD) - a case report
ea0063gp11
Functional mixed oncocytic adrenocortical neoplasm presenting as an asymptomatic adrenal mass
ea0063gp12
KCTD20, a new gene in cortisol-secreting adrenocortical tumors related to inactivating mutations of the Carney Complex gene (PRKAR1A)
ea0063gp13
Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) as a novel therapeutic approach in highly-selected pancreatic functioning and non-functioning neuroendocrine neoplasms (pNENs) patients: Preliminary report
ea0063gp14
Calcium and Bone 1
Recombinant human parathyroid hormone 1-84 for the treatment of adults with chronic hypoparathyroidism: Six-year safety and efficacy results of the RACE study
ea0063gp15
The effect of parathyroidectomy on glucose homeostasis and incretin hormone release in patients with primary hyperparathyroidism: a pilot study
ea0063gp16
Utility of a second technecium99mMIBI-SPECT imaging before re-operating in patients with persistent sporadic primary hyperparathyroidism: results of a retrospective multicentric study
ea0063gp17
Calcium to Phosphorus (Ca/P) ratio as an accurate index for the diagnosis of primary hyperparathyroidism (PHPT) and hypoparathyroidism (HypoPT)
ea0063gp18
18F-Fluorocholine PET/CT in patients with primary Hyperparathyroidism and negative or inconclusive 99mTc-MIBI parathyroid scan: clinico-pathological correlations
ea0063gp19
Clinical, biochemical and radiological profile of normocalcaemic hyperparathyroidism: a multicentric cross-sectional evaluation
ea0063gp20
The long-term outcomes of chronic post-surgical hypoparathyroidism
ea0063gp21
OFELIA - Prevalence of osteoporosis in fragility fracture patients
ea0063gp22
Study of hsa-miR-30e miRNA as a biomarker in identifying multiple gland disease in sporadic primary hyperparathyroidism: Is it time for individualized molecular-based surgery?
ea0063gp23
The impact of impaired calcium-phosphorus metabolism on the renin-angiotensin-aldosterone system in patients with primary hyperparathyroidism
ea0063gp24
Impact of chronic hypoparathyroidism on health-related quality of life, symptoms, employment, and relationships: findings from a 13-country patient survey
ea0063gp25
Diabetes and Cardiovascular Disease
Association of MR-proANP with cardiovascular risk factors in middle aged patients with diabetes mellitus type 2 and non-diabetic controls
ea0063gp26
Serum insulin levels are associated with vulnerable plaque components in the carotid artery
ea0063gp27
The synergistic impact of apolipoprotein B/ A-1 and lipoprotein (a) on coronary artery calcification
ea0063gp28
Systematic screening of masked hypertension in normotensive type 2 diabetic patients
ea0063gp29
Cardiovascular risk factors in patients with type 2 diabetes and non-alcoholic fat liver disease
ea0063gp30
Abstract unavailable
ea0063gp31
Breastfeeding is inversely associated with subclinical atherosclerosis in postmenopausal women
ea0063gp32
Application of 3D skin culture model as a tool to study the role of immune mechanisms in chronic diabetic foot ulcers pathogenesis
ea0063gp33
Stroke in diabetic patients and cardiovascular risk factors control
ea0063gp34
Cardiovascular biomarkers and calculated risks - an association study
ea0063gp35
Family education, quality of life and glycosylated haemoglobin control among Nigerian diabetics: a quasi-experimental study
ea0063gp36
Metabolic Syndrome and Hypoglycaemia
Abstract unavailable
ea0063gp37
Beta cell senescence: effect of glucotoxicity and glucolipotoxicity
ea0063gp38
Generalized lipodystrophy associated with delayed neuro-somatic development and multiple dysmorphisms in a neonate with a compound heterozygous missense mutation in the SYNE2 gene
ea0063gp39
Long-term administration of Empagliflozin may promote hepatic and renal lipid accumulation, and inflammation in the APOE knockout model
ea0063gp40
Applying the Bradford Hill criteria to evaluate the association between hypoglycaemia and cardiovascular events/mortality (CVEM) [Data from meta-analysis (MA), Randomized Controlled Trials (RCTs), and observational outcome studies (OBS)]
ea0063gp41
Magnitude of effects of testosterone replacement therapy on testosterone normalization, parameters of metabolic syndrome and vascular function and morphology in obese hypogonadal patients with type 2 diabetes - the SETH2 study
ea0063gp42
The elevated chemerin plasma concentrations in men diagnosed with metabolic syndrome are correlated with markers of low-grade state inflammation but not with SHBG serum levels and accompanying hypoandrogenemia.
ea0063gp43
Effects of anti-inflammatory treatment on fibroblast growth factor-21 in obesity and metabolic syndrome
ea0063gp44
Hypoglycemia and dementia risk in older patients with type 2 diabetes: a propensity-score matched analysis of a population-based cohort study
ea0063gp45
Characteristics and management of Type 1 diabetes mellitus patients with diabetic ketoacidosis
ea0063gp46
Awareness, treatment rates and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable and definite familial hypercholesterolemia
ea0063gp47
Acromegaly and GH
Prolonged diagnostic delay in acromegaly is associated with long-term morbidity and excess mortality: data from a nationwide study
ea0063gp48
Pharmacokinetics of somapacitan in individuals with renal impairment: an open-label, parallel group, phase 1 study
ea0063gp49
Sleep disorders and cognitive dysfunction in acromegaly
ea0063gp50
Prognostic value of short-acting pasireotide test for response prediction to pasireotide LAR in patients with acromegaly resistant to first-generation analogs. Can a short-acting pasireotide test predict the response of long-acting pasireotide treatment in patients with acromegaly resistant to first generation somatostatin analogs?
ea0063gp51
Final height in childhood onset hypopituitarism
ea0063gp52
Efficacy and safety of once-weekly somapacitan in adult growth hormone deficiency (AGHD) confirmed in a 53-week REAL-1 trial extension
ea0063gp53
Pharmacokinetics in patients with prolactinomas
ea0063gp54
Acromegaly do not increase the risk of vertebral fractures: a retrospective and prospective study on 50 patients
ea0063gp55
Sclerostin and fracture risk assessment in acromegaly
ea0063gp56
Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study
ea0063gp57
ACROSTUDY - safety and efficacy in a cohort of 110 Naive patients with acromegaly treated with pegvisomant
ea0063gp58
Effects of pegvisomant and pasireotide LAR on incidence of vertebral fractures in patients with acromegaly resistant to treatment with first-line somatostatin analogs
ea0063gp59
Metabolic outcome in adolescents with growth hormone deficiency during transition phase
ea0063gp60
Reproductive Axis
Novel phenotype of isolated diminished ovarian reserve and new CSB-PGBD3 (ERCC6) mutations revealed by targeted next generation sequencing in a cohort of caucasian infertile women
ea0063gp61
Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, Mkrn3
ea0063gp62
A KISS1R gene variant in a pedigree with maternally inherited precocious puberty
ea0063gp63
Untargeted lipidomics profiling by high-performance liquid chromatography/time-of-flight mass spectrometry in polycystic ovary syndrome: candidate biomarkers and association to disease traits
ea0063gp64
Testosterone replacement therapy outcomes in subjects with Klinefelter syndrome: preliminary results from a meta-analysis study
ea0063gp65
Diet patterns in patients with PCOS
ea0063gp66
MRI-based proton-density fat fraction measurements reveal alterations of abdominal fat, bone and muscle composition in lean women with PCOS
ea0063gp67
DHT, rather than free testosterone, influences symptoms of aging in eugonadal men
ea0063gp68
Male patients with hypogonadism have an impaired lipoprotein function
ea0063gp69
Thyroid Autoimmune Disorders
Serum levels of the soluble receptor for advanced glycation end products (AGEs) are reduced and AGEs increased in hashimoto's thyroiditis (HT)
ea0063gp70
The randomised probiotic trial of indigo study (investigation of novel biomarkers and definition of role of the microbiome in Graves' orbitopathy)
ea0063gp71
Microarray profile of CD19+B cells from Graves' disease patients reveals potential molecular mechanisms associated with the proliferation of B cell signaling
ea0063gp72
Clinical experiences in autoimmune polyglandular diseases
ea0063gp73
The change of pulmonary artery pressure and serum vascular endothelial growth factor in Graves' disease before and after treatment
ea0063gp74
Grave's orbitopathy: clinical, paraclinical and therapeutic features
ea0063gp75
Cardiovascular risk factors, autoimmunity and insulin resistance in Graves disease
ea0063gp76
Lipid profile, insulin resistance and cytokines evaluation in autoimmune thyroiditis patients
ea0063gp77
Autoimmune thyroiditis, Graves' disease and adiponectin, resistin and plasminogen activator inhibitor-1 levels
ea0063gp78
The neutrophil-to-lymphocyte ratio as a novel marker in patients with thyroid-associated orbitopathy - a prelimininary study
ea0063gp79
Effect of nine months of vitamin D supplementation on muscle performance in Graves' disease: a double-blinded, randomized clinical trial
ea0063gp80
Retrospective analysis of the efficacy of three different dose regimens of rituximab in patients with active moderate-severe graves' orbitopathy
ea0063gp81
Thyroid Nodules and Cancer
Coexistence of the BRAF V600E and TERT promoter mutations and their impact on response to therapy and final outcome of papillary thyroid cancer
ea0063gp82
Prognostic significance of TERT promoter and BRAF mutations in cytologically suspicious or malignant thyroid nodules: a monocentric case series at a tertiary-level endocrinology unit
ea0063gp83
Polygenic susceptibility to papillary thyroid cancer: detection of the main genetic signature in Italian patients
ea0063gp84
Follistain-like 1 (Fstl1) may reduce metastastic activity of anaplastic thyroid cancer by increasging thyroid transcription factor 1 (TTF1) and epithelial gene markers
ea0063gp85
Benefits and limitations of TKIs in patients with medullary thyroid cancer: a systematic review and meta-analysis
ea0063gp86
Intronic RAS and PI3KCA mutations identified by Next Generation Sequencing in thyroid nodules with indeterminate cytology may associate with follicular thyroid cancer
ea0063gp87
An analysis of false-positive uptake on radioiodine whole-body scintigraphy
ea0063gp88
Prospective sonographic assessment of 214 consecutive nodules as per the ATA 2015 guidelines. Real world data
ea0063gp89
Treatment modalities in DTC patients with neck disease persistence. Second surgical intervention is more beneficial than only radioiodine (RAI) treatment
ea0063gp90
Detection of EIF1AX>, CHEK2 and PPM1D gene variants in thyroid carcinomas
ea0063gp91
Diagnostic performance evaluation of a computer-assisted imaging analysis system for ultrasound risk stratification of thyroid nodules
ea0063gp92
Tirads classification and final diagnosis of thyroid nodules classified as bethesda-3 after fine-needle aspiration
ea0063gp93
Adrenal and Neuroendocrine - Basic
Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells
ea0063gp94
The role of filamin A (FLNA) in the regulation of IGF2/IGF1R pathway in adrenocortical carcinomas
ea0063gp95
An unusual association of P450 oxidoreductase Deficiency and Argininosuccinatelyase Deficiency
ea0063gp96
Structural changes in the zona glomerulosa of normal aging adrenals
ea0063gp97
Methylation status and gene expression of steroidogenic enzymes in benign adrenocortical tumors
ea0063gp98
Implementation of two preclinical ACC models for a comparative drug screen and initial mechanistic investigations
ea0063gp99
Characterization of cell death induced by mitotane in adrenocortical carcinoma cells
ea0063gp100
Infiltrating CD68+/CD163+ macrophages regulate Gonadotroph-tumour invasion through collagen remodelling
ea0063gp101
Development of a simple experiment to distinguish ARMC5 missense mutants from rare ARMC5 polymorphisms in PBMAH patients using a quantitative western blot approach
ea0063gp102
Abstract unavailable
ea0063gp103
Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas
ea0063gp104
Reappraisal of the human adrenal cortex and fate
ea0063gp105
Gene expression changes in visceral adipose tissue of Cushing syndrome.
ea0063gp106
Abstract unavailable
ea0063gp107
Calcium and Bone 2
Exploring the mechanism of TGF-[beta]1 signaling in counteracting BMP activities during the osteogenesis of mesenchymal stem cells
ea0063gp108
Sex steroids as determinants of Wnt-Signalling markers in men
ea0063gp109
Denosumab in post-liver transplantation osteoporosis: preliminary data on the effects on bone mineral density and turnover markers
ea0063gp110
Hip structure analyses in acromegaly: Decrease of cortical bone thickness after treatment
ea0063gp111
Body composition determines muscle strength in osteoporotic patients with vertebral fractures
ea0063gp112
Vertebral fracture in outpatients with type 2 diabetes mellitus
ea0063gp113
Qualitative and quantitative parameters of diabetic osteopathy in type 1 diabetes mellitus
ea0063gp114
Different impact of marrow and visceral adipose tissue on bone phenotype
ea0063gp115
FGF-23 beyond the kidney: a new bone mass regulator in the general population
ea0063gp116
Bone health and final height in craniopharyngioma patients.
ea0063gp117
Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1
ea0063gp118
Diabetes: Late Complications
Glycemic variability and mortality in patients hospitalized to general surgery wards
ea0063gp119
High prolactin levels within the normal range are associated with improved metabolic profile and lower carotid intima media thickness in premenopausal women
ea0063gp120
The A allele of the rs4636297 (G/A) polymorphism in the microRNA-126 is associated with protection for diabetic retinopathy
ea0063gp121
Vitamin D supplementation and dynamics of LDF skin microcirculation in patients with diabetes mellitus and diabetic polyneuropathy
ea0063gp122
Four out of five patients with type 2 diabetes mellitus have hearing loss
ea0063gp123
Unrecognized high risk for diabetic foot ulcer among hospitalized patients
ea0063gp124
Vitamin D3 deficiency is associated with more severe insulin resistance and metabolic profile in patients with type 2 diabetes
ea0063gp125
Depression and associated risk factors in older adults with diabetes: the 2010-2011 Korean national health and nutrition examination survey
ea0063gp126
Genetic polymorphisms in patients with type 2 diabetes mellitus and coronary heart disease
ea0063gp127
Clinical and metabolic characteristics of a population of diabetic patients previously educated having fasted all month of Ramadan
ea0063gp128
Efficiency of application of silicate sorbents in surgical treatment of patients with neuro-ischemic form of diabetic foot ulcer
ea0063gp129
Obesity
Glucagon activity in human adipose precursors
ea0063gp130
A Study of the Effect of Laparoscopic Mini Gastric Bypass Versus Sleeve Gastrectomy On Obese Type 2 Diabetic Patients
ea0063gp131
Variants in genes of the leptin / melanocortin pathway are involved in 3% of cases of early-onset severe obesity
ea0063gp132
Effect of IL1-receptor antagonist on renin-angiotensin-aldosterone system and hemodynamics in obese individuals
ea0063gp133
Higher habitual intakes of dietary carbohydrates are associated with leptin gene expression in visceral and subcutaneous adipose tissues among non-diabetic people
ea0063gp134
Obesity is associated with a downregulation of UCP2 and miR-133a-3p but not NLRP3 in subcutaneous adipose tissue
ea0063gp135
Administration of a growth hormone bolus down-regulates gene-expression of the g0/g1 switch gene 2 (g0s2) in subcutaneous adipose tissue in healthy, obese men: a randomized, placebo-controlled, cross-over study
ea0063gp136
Empagliflozin as well as Anakinra reduce symptomatic hypoglycemia in patients after Roux-Y-gastric bypass by lowered insulin secretion
ea0063gp137
Androgen metabolism during weight loss in men with obesity
ea0063gp138
Prediction of clinically significant weight loss with Gelesis100 in the GLOW study as early as 8 weeks post-treatment
ea0063gp139
The efficacy of complex kinesiotherapy in weight loss and muscle function improving in obesity patients
ea0063gp140
Dietary inflammatory index is differently associated with ectopic fat depots in overweight and obese adults
ea0063gp141
Interdisciplinary Endocrinology 1
Impact of age and metabolic profile on the definition of 12 circulating steroid reference intervals measured by LC-MS/MS in an Italian healthy adult male cohort
ea0063gp142
Impact of age, menstrual phase, menopausal status and metabolic profile on the definition of 12 circulating steroid reference intervals measured by LC-MS/MS in an Italian healthy adult female cohort
ea0063gp143
Bilateral femoral head necrosis with low dose oral corticosteroid therapy for pan-hypopituitarism
ea0063gp144
Final (FH) and target height (TH) in male and female patients with congenital hypogonadotropic hypogonadism (CHH)/Kallmann syndrome (KS): a monocentric study of 216 patients
ea0063gp145
Turner syndrome: mental health and social skills from childhood to emerging adulthood
ea0063gp146
Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study
ea0063gp147
Risk of myocardial infarction (MI), stroke, and other cardiovascular (CV) conditions in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study
ea0063gp148
Risk of chronic kidney disease (CKD) and CKD progression in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study
ea0063gp149
Increased prevalence of overweight and obesity and its clinical predictors in children affected by x-linked hypophosphatemia
ea0063gp150
MEN4: is there a link with autoimmunity?
ea0063gp151
UMD-MEN1 database: analysis of clinical and genetic data from 1,676 patients by the TENGEN network
ea0063gp152
Cushing's
Evaluation of the corticotrophin-releasing-hormone test and the high dose dexamethasone suppression test in ACTH dependent Cushing's syndrome: a 25-year prospective cohort study
ea0063gp153
Pathway enrichment analysis in functioning and silent corticotroph pituitary adenomas reveals mechanisms to explain their distinct clinical behaviour
ea0063gp154
Endocrine immune-related adverse events following immune checkpoint inhibitors in patients with advanced melanoma: single-center retrospective analysis
ea0063gp155
Correlation between responsiveness to CRH stimulation test in Cushing's disease patients and USP8 mutational status
ea0063gp156
DNA Methylation and fMRI responses in patients with Cushing's syndrome in remission - suggestions of a functional link between hypercortisolism and neurocognitive dysfunction
ea0063gp157
Cortisol and cortisone assays in hair by mass spectrometry for the diagnosis of Cushing's syndrome
ea0063gp158
Skeletal muscle fatty infiltration in the thigh, as assessed by MRI T2-weighted and 3-point Dixon sequences, is associated with poor performance on muscle function testing in patients with Cushing's syndrome in remission
ea0063gp159
Brain 18F-fluorodeoxyglucose PET/CT in localization of MRI-negative ACTH-producing pituitary adenomas
ea0063gp160
Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells
ea0063gp161
Pharmacokinetics of osilodrostat following single and multiple doses of osilodrostat in healthy subjects and patients with Cushing's disease
ea0063gp162
Effects of a single dose of pasireotide on glucose metabolism in patients with Cushing's disease and predictors of diabetes mellitus developement during treatment
ea0063gp163
Assessment of bone marrow fat by single-voxel vertebral magnetic resonance spectroscopy in cushing's syndrome with or without vertebral fractures
ea0063gp164
Obesity (1)
Role of invasive and non-invasive diagnostic tests in differential diagnosis of ACTH-dependent Cushing's syndrome
ea0063gp165
Results from the phase 3 multicenter SONICS study of levoketoconazole: subgroup analysis of Cushing's syndrome patients with diabetes mellitus
ea0063gp166
Epigenetic regulation by miRNAs in corticotroph tumors
ea0063gp167
Evaluation of utility of salivary cortisol levels after suppression with 1 mg Dexamethasone in screening of Cushing's syndrome
ea0063gp168
The role of copeptin and cortisol in critically ill patients
ea0063gp169
Microstructural white matter changes using diffusion tensor imaging in patients with Cushing's disease
ea0063gp170
A new generation somatostatin-dopamine chimeric analogue exerts potent antitumoral actions on primary pituitary neuroendocrine tumor cells
ea0063gp171
Pituitary surgery as first-line therapy for microprolactinomas
ea0063gp172
Excellent tumor response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma
ea0063gp173
Sleep disorders after craniopharyngioma surgery
ea0063gp174
Normal IGF-bioactivity and low free IGF-I in patients with Prader-Willi syndrome with high total serum IGF-I: immunoreactive IGF-I concentrations poorly reflect IGF bio-activity and bio-availability
ea0063gp175
Benign Thyroid Disorders
Do different initial doses of L-T4 within the range of 10-15 mcg/kg/die influence neurodevelopment during the first two years of life in children with congenital hypothyroidism?
ea0063gp176
Abstract unavailable
ea0063gp177
Cystic fibrosis as a novel cause of thyroxine (l-t4) malabsorption and increased requirement
ea0063gp178
Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II
ea0063gp179
Urinary concentration of iodotyrosines correlates with the severity of iodine deficiency in dehal1 knockout mice
ea0063gp180
Effect of anti-streptavidin interference when diagnosing thyroid disease using immunoassay analyses
ea0063gp181
Can hepcidin be a useful marker in the diagnosis and monitoring of de Quervain thyroiditis?
ea0063gp182
High-dose intravenous levothyroxine treatment as a successful, safe and clinically effective therapy option in severe hypothyroidism: a retrospective study
ea0063gp183
Effect of restoration of thyroid function on body composition, insulin resistance and visfatin concentrations in women with hypo- and hyperthyroidism
ea0063gp184
Thyroid-related adverse events in patients treated with Nivolumab and Pembrolizumab
ea0063gp185
Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus
ea0063gp186
Adrenal and Neuroendocrine - Clinical
Primary adrenal insufficiency in children: results from a large nationwide cohort
ea0063gp187
Increased risk of infections in Addison's disease and congenital adrenal hyperplasia patients: a longitudinal study based on a United Kingdom primary care database
ea0063gp188
Plasma renin concentration is associated with cardiac function and morphology in primary adrenal insufficiency
ea0063gp189
Management and outcome of pregnancies in women with adrenal insufficiency: experience from a retrospective European study
ea0063gp190
Pneumocystis pneumonia as a major complication of medical treatment for severe Cushing's syndrome linked either to ectopic ACTH secretion or to Cushing's disease
ea0063gp191
Diagnostic accuracy of captopril challenge test and saline infusion test in patients at high risk for primary aldosteronism
ea0063gp192
Comparison of whole-genome expression analysis in patients with secondary adrenal insufficiency treated with conventional treatment versus modified-release hydrocortisone
ea0063gp193
New perioperative imaging techniques, immunohistochemistry and genetic analysis to investigate the suitability of laparoscopic partial adrenalectomy in primary aldosteronism
ea0063gp194
Evaluation of clinical and biochemical cure and adrenal CYP11B2 and CYP11B1 immunostaining in primary aldosteronism operated after adrenal venous sampling
ea0063gp195
Sexual function in adrenal insufficiency: data from the DREAM trial
ea0063gp196
Optimizing mineralocorticoid replacement therapy in patients with congenital adrenal hyperplasia and Addison's disease
ea0063gp197
Analysis of circulating microRNAs in primary aldosteronism
ea0063gp198
LC-MS/MS measurement for urinary aldosterone improves primary aldosteronism screening
ea0063gp199
Diabetes: Pharmacotherapy
A liver selective knockdown of Dpp4 by therapeutic siRNA affects lipid metabolism but fails to improve glucose control in diabetic mice
ea0063gp200
Blood intact incretin levels are related to beta-cell function and glycemia in patients with type 2 diabetes
ea0063gp201
The growth hormone effect blocked with pegvisomant did not alter the free fat acid plasma concentration in pre-diebetic or type 2 diabetic patients treated with empagliflozin
ea0063gp202
Effects of cardiovascular function of SGLT-2 inhibitos versus DPP-4 inhibitors in type 2 diabetes with coronary artery disease
ea0063gp203
Fasting insulin levels correlate with the incidence of hypoglycemic events in patients with Type 2 Diabetes treated with sulfonylureas: a retrospective cross-sectional study
ea0063gp204
Metabolic changes in men undergoing androgen deprivation therapy for prostate cancer
ea0063gp205
Antioxidant and hypoglycemic effects of gossitan
ea0063gp206
Treatment with sitagliptin in patients with type 1 diabetes and type LADA diabetes
ea0063gp207
Effects of glucagon-like peptide 1 receptor agonist on short-chain fatty acids, carbohydrate and lipid metabolism in patients with type 2 diabetes
ea0063gp208
Efficacy and tolerability of dulaglutide in patients with type 2 diabetes: Experience on a secondary Hospital
ea0063gp209
Empagliflozin inhibits apoptosis of pancreatic beta-cells through amelioration of ER-stress.
ea0063gp210
New insights on strain-specific impacts of probiotics on insulin resistance
ea0063gp211
Gestational and Type 1 Diabetes
Prevalence of gestational diabetes during 14 pregnancies of acromegalic women
ea0063gp212
The impact of the intrauterine hyperglycaemia on the expression of genes related to cardio-metabolic diseases in human umbilical vein endothelial cells: results from a randomised, controlled study of different glycaemic targets during gestational diabetes treatment
ea0063gp213
Association between sleep disturbances and fear of hypoglycemia in adults with type 1 diabetes, data from VARDIA Study
ea0063gp214
Brain volume and variability of glycemia in patients with type 1 diabetes mellitus
ea0063gp215
Specific pattern of insulin delivery during pregnancy in tightly controlled type 1 diabetic patients treated with insulin pump; unchanged total daily insulin dose per kilogram with consecutive basal/prandial insulin ratio adjustment
ea0063gp216
The rs2304256 A allele in the TYK2 gene is associated with protection for type 1 diabetes mellitus in a Brazilian population
ea0063gp217
Effect of HbA1c and hyperglycemia on hemostasis in patients with type 1 diabetes
ea0063gp218
Impact of type 1 diabetes mellitus and its complications on markers of nitric oxide metabolism
ea0063gp219
Definition of a third-trimester HbA1c cut-off point for an increased risk of Large-for-Gestational-Age in mothers with Gestational Diabetes
ea0063gp220
Insulin requirements during lactation in women with diabetes mellitus type 1 in comparison with pre-pregnancy levels - a retrospective study
ea0063gp221
The impact of gestational weight gain on subclinical atherosclerosis, placental circulation and neonatal complications
ea0063gp222
Adrenal and Neuroendocrine - Clinical (1)
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosis
ea0063gp223
Caffeine upregulates hepatic SHBG production by increasing adiponectin in white adipose tissue
ea0063gp224
Activation of the ATM/Akt/CREB/eNOS expression signaling axis by aphidicolin increases nitric oxide production to attenuate endothelial cell death
ea0063gp225
Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma - final Results of the phase 0 'Lumed' Study
ea0063gp226
Multikinase inhibitors for the treatment of progressive, metastatic parathyroid cancer
ea0063gp227
Serine-threonine PAK1 as a novel common node for estrogen- and prolactin-dependent pathways in breast cancer
ea0063gp228
Melatonin prevented beta cell senescence against glucolipotoxicity
ea0063gp229
Low-dose pollutant mixture triggers metabolic disturbances in ovariectomized mice and comparison with the effects of 17[beta]-estradiol (E2) treatment
ea0063gp230
In vitro effects of bisphenol A and its analogs on human melanocortin 4 receptor
ea0063gp231
Can phthalates impair liver function?
ea0063gp232
Anterior and Posterior Pituitary
Evaluation of postoperative copeptin concentration as a predictive factor of diabetes insipidus after pituitary surgery. preliminary results
ea0063gp233
Is the molecular study of pituitary transcription factors useful in the identification of Pituitary Neuroendocrine Tumor subtypes according to the new WHO 2017 criteria?
ea0063gp234
The effect of previous optic chiasm compression on the post-illumination pupil response in pituitary patients
ea0063gp235
Characteristics and natural history of a large cohort of non-functioning pituitary incidentalomas: a two-centers study
ea0063gp236
Diagnostic accuracy of copeptin in the diagnosis of diabetes insipidus after pituitary surgery
ea0063gp237
Immune checkpoint inhibitors therapy-induced hypophysitis is frequently associated with previous thyroid disorders: results from ImmuCare study
ea0063gp238
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature
ea0063gp239
Adrenal axis deterioration in the families/sporadic patients with PROP1 mutation, over 30 years of single center longitudinal observation
ea0063gp240
Inflammatory response to osmotic stimulus in healthy volunteers
ea0063gp241
Copeptin levels in SIADH - a marker of malignant disease?
ea0063gp242
Histological classification of pituitary neuroendocrine tumors: genomic insights on cell lineage
ea0063gp243
Tomosyn negatively regulates arginine vasopressin secretion in embryonic stem cell-derived neurons
ea0063gp244
Disturbances of Reproduction
MRI detection of aortic anomalies in 204 adult patients with Turner syndrome: a longitudinal study
ea0063gp245
Is monosomia related to poorer cardiometabolic state in Turner syndrome?
ea0063gp246
The efficacy of long-term metformin treatment in overweight and obese women with PCOS: A 10-year database study
ea0063gp247
Gut microbiota-dependent cardiometabolic risk and oral contraceptive use in polycystic ovary syndrome: A prospective study
ea0063gp248
Maternal 3rd trimester cortisol status was associated with offspring sex and PCOS status. Odense Child Cohort
ea0063gp249
Diagnostic potential of a 'mouse azoospermia' gene panel in human azoospermia: identification of novel genetic causes of meiotic arrest
ea0063gp250
Free Testosterone (FT) is inversely related to frailty in Human Immunodeficiency Virus (HIV)-Infected Men
ea0063gp251
Prolactin and prostate: an observational case-control study in men with prolactinoma under cabergoline treatment
ea0063gp252
Genetic architecture of greek patients with isolated GnRH deficiency
ea0063gp253
Thyroid Nodules and Cancer 2
Recurrent laryngeal nerve liberation technique for phonation recovery
ea0063gp254
Are clinicopathological features of isthmic thyroid nodules different from nodules located in thyroid lobes?
ea0063gp255
Impact of age at the diagnosis of radioiodine resistance in differentiated thyroid cancer patients
ea0063gp256
Effects of hospital volume on clinical outcomes after thyroidectomy - a Swiss nation-wide study
ea0063gp257
Predictors of malignancy in thyroid FNA classified as high-risk indeterminate lesions (TIR3B): combining ultrasonographic and cytology features
ea0063gp258
Sentinel lymph node biopsy using methylene blue dye in clinically N0 papillary and medullary thyroid carcinomas for decision on one-time lateral neck dissection
ea0063gp259
Factors influencing nodular goiter - An analysis of the growth rates in long-term follow-up patients
ea0063gp260
Evaluating effects of thyrotrophin receptor antibody positivity on cytology and histopathology in patients with graves disease
ea0063gp261
Classification of thyroid nodules by ultrasound in clinical practice: the added value of the judgment of the skilled endocrinologist
ea0063gp262
Predictive factors of short and long-term vandetanib response in locally advanced or metastatic medullary thyroid cancer: a single center experience
ea0063gp263
Assessment of different ti-rads systems using computer-aided detection technology
ea0063gp264
Poster Presentations
Adrenal and Neuroendocrine Tumours 1
A novel heterozygous mutation in exon 3 of VHL gene leading to Von Hippel-Lindau disease in a Turkish family
ea0063p1
Long evolution of Connshing syndrome?
ea0063p2
Effect of Glucocorticoid receptor antagonist administration in a Cushing's syndrome model rat
ea0063p3
Ectopic adrenocorticotropic hormone (ACTH-ectopic) syndrome and osteoporosis: Rare cases and difficult treatment
ea0063p4
Paraganglioma of the urinary bladder wall: 2 cases with 2 different presentations
ea0063p5
Adrenal insufficiency secondary to bilateral adrenal diffuse large B-cell lymphoma: a case report
ea0063p6
A rare association of Adrenocortical carcinoma with haematological and breast malignancy in a young female
ea0063p7
Metabolic and cardiovascular profile of 143 adrenal incidentalomas
ea0063p8
HNRNP Q suppresses polyglutamine huntingtin aggregationby post-transcriptional regulation of Vaccinia-related kinase 2
ea0063p9
Study of body composition and phase angle in relation to nutritional parameters in patients with neuroendocrine tumors
ea0063p10
A case series of two patients with intrapericardial paragangliomas
ea0063p11
Combined autophagy and mTOR inhibition reduces cells proliferation and induces apoptosis in a lung carcinoid in-vitro model
ea0063p12
Pheochromocytoma - 3 sides of the same story
ea0063p13
Analysis of the 22-years experience of surgical treatment of adrenal tumor in single specialized endocrinological center
ea0063p14
Immunohistochemical characteristics of adrenal tumors in patients with primary aldosteronism
ea0063p15
Cortex protecting surgery in MEN 2A
ea0063p16
Unilateral non-haemorrhagic adrenal infarction (NHAI) as a cause of abdominal pain during pregnancy
ea0063p17
Evaluating the applicability of urinary miR-483-5p as a non-invasive marker in adrenocortical cancer patients
ea0063p18
Allgrove syndrome (Triple A syndrome): A case report
ea0063p19
A case series of metastatic pheochromocytomas and paragangliomas: patients characteristics, therapeutic approach and follow-up
ea0063p20
Retroperitoneal paraganglioma: clinical case
ea0063p21
The frequency of confirmed primary hyperaldosteronism in patients with high aldosteron renin ratio
ea0063p22
Evaluation of angiotensin II in primary aldosteronism and other forms of hypertension - a preliminary study
ea0063p23
Management of adjuvant mitotane therapy for adrenocortical carcinoma: a survey in Italy
ea0063p24
Management of mitotane for advanced adrenocortical carcinoma: a survey in Italy
ea0063p25
How do sex and BMI affect glucocorticoid treatment in adrenal insufficiency?
ea0063p26
Abstract unavailable
ea0063p27
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
ea0063p28
Pheocromocytoma, newly diagnosed during pregnancy in a subject with neurofibromatosis type 1: A case report and review of literature
ea0063p29
Becoming of patients with primary aldosteronism according to their treatment
ea0063p30
Predictors of bilateral and unilateral primary aldosteronism: a retrospective observational study
ea0063p31
18-oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status
ea0063p32
Complete remission of a highly aggressive, metastasized, SDHB-related paraganglioma after chemotherapy with CVD and peptide-receptor radiotherapy
ea0063p33
Aldosterone measurement in the Diagnosis of primary aldosteronism - comparison between two automated immunoassays and two liquid chromatography tandem mass-spectrometry methods
ea0063p34
Embolization of the adrenal artery to control severe adrenal hemorrhage
ea0063p35
Vitamin D deficiency is a predictor marker of tumor aggressiveness in sporadic and MEN1-related well-differentiated, low-grade GEP-NET
ea0063p36
Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas
ea0063p37
Influence of Tumor Microenviroment in response modulation to treatment in human BP-NENs
ea0063p38
A novel CYP11B1 mutation presenting as a classical congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency
ea0063p39
Available 3D cultures methods: study on a Pancreatic Neuroendocrine Neoplasm cell line
ea0063p40
Prevalence and prognosis of bone metastases in pancreatic and small intestinal neuroendocrine tumours
ea0063p41
Endocrine hypertension?
ea0063p42
Ninety-four serum steroids measured by gas chromatography tandem mass spectrometry (GC-MS/MS) in patients with Cushing's syndrome
ea0063p43
Comparative study between autoimmune metaplastic atrophic gastritis (AMAG) and type 1 gastric neuroendocrine tumors (G-NETs) in Hospital Clinico San Carlos (HCSC), Madrid
ea0063p44
Pheochromocytoma and disorders of carbohydrate metabolism
ea0063p45
Heart and vessels after a pheochromocytoma: which outcomes?
ea0063p46
First presentation of Addison's disease as hyperkalaemia: a rare case report
ea0063p47
Pharmacokinetic Interaction Study of the Effects of Multiple-dose Gastric Acid Reducers Omeprazole (OMP) and Famotidine (FAM on the Pharmacokinetics (PK) of Single-dose Telotristat Etiprate (TE) in Healthy Subjects
ea0063p48
Endocrine hypertension: before and after treatment of the endocrinopathy
ea0063p49
A seminoma with entrapped nerve ganglion masquerading as a paraganglioma
ea0063p50
Magnetic resonance imaging in the initial diagnosis of pancreatic insulinoma: primary data analysis
ea0063p51
Exome analysis of pituitary adenoma tissue derived cell cultures
ea0063p52
A rare association of neuroendocrine tumor with adenocarcinoma of ampulla of vater: difficulties for diagnosis and effects of multi therapeutic approach
ea0063p53
Continuous glucose monitoring during the prolonged fast test for the diagnosis of hypoglycemic diseases: primary data analysis
ea0063p54
Clinical case of a repeated life-threatening upper gastrointestinal bleeding due to previously unknown primary hyperparathyroidism
ea0063p55
A difficult diagnosis: pheochromocytoma or methamphetamine abuse?
ea0063p56
Association of the BclI glucocorticoid receptor polymorphism with body composition and metabolic parameters in female patients with adrenal incidentalomas
ea0063p57
A case of Von Hippel-Lindau disease with bilateral pheochromocytoma and ectopic hypersecretion of intact parathyroid hormone
ea0063p58
Adrenal pheocromocytoma during childhood - a case report
ea0063p59
Adrenal morphology in a large cohort of adult subjects with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
ea0063p60
Calcium and Bone 1
Vitamin D status and linear growth in a sample of Egyptian adolescents
ea0063p61
The effectiveness of colecalciferol and selective vitamin D receptor agonists treatment on secondary hyperparathyroidism in chronic kidney diseases patients
ea0063p62
Osteoporosis in developing-nations: need for centralized-data-collection & treatment-guidance centers to study epidemiology
ea0063p63
Prevalence and the main risk factors for vitamin D deficiency in pregnant women living in a locality of Algiers
ea0063p64
Effects of dexamethasone for calcium channels and mucin-related genes regulation on A549 cell line
ea0063p65
Regulatory effect of dexamethasone on tracheal calcium processing proteins and mucosal secretion
ea0063p66
The effect of steroid hormone on the expression of the calcium-processing proteins in the immature rat brain
ea0063p67
Distribution of and steroid hormone effects on calbindin-D9k in the immature rat brain
ea0063p68
Pledoary for using Trabecular Bone Score as a method for osteoporosis diagnosis, not only for the risk
ea0063p69
Relationship between leptin level, body mass index and parathyroid hormone in chronic hemodialysis patients
ea0063p70
Challenging clinical case of primary hyperparathyroidism caused by atypical adenoma
ea0063p71
Severe hypocalcemia: when the skin expresses itself
ea0063p72
Ultrasound detection of parathyroid hyperplasia in patients with chronic kidney disease treated by dialysis
ea0063p73
Multiple fragility fractures in young female patients caused by FGF23-induced hypophoshatemic osteomalacia
ea0063p74
Clinical significance of parathyroid incidentalomas during thyroidectomy: a South Indian experience
ea0063p75
Value of ultrasonography guided fine-needle-aspiration in the diagnosis of an intrathyroidal parathyroid adenoma associated with thyroid pathology
ea0063p76
The effect of parathyroidectomy on the BMD in postmenopausal women with mild primary hyperparathyroidism: the results of comparative retrospective dynamic study
ea0063p77
Obstructive urolithiasis as first sign of primary hyperparathyroidism caused by a large parathyroid hyperplasia
ea0063p78
Parathyroid adenoma in pregnancy: a case report
ea0063p79
Effects of bariatric surgery on bone health
ea0063p80
A rare case of hypoparathyroidism due to MELAS syndrome
ea0063p81
A case report of tumor-induced osteomalacia
ea0063p82
Pregnancy-related osteoporosis: a series of cases
ea0063p83
Bone mineral density, prevalence of fractures, antiosteoporotic drugs effectiveness and Ca/Vit D supplementations intake in elder patients with osteoporosis: a cross-sectional study on Moscow population
ea0063p84
Brown tumor of the palate as first manifestation of a primary hyperparathyroidism
ea0063p85
Difference in trabecular bone score according to spine-femur bone mineral density discordances in healthy postmenopausal women
ea0063p86
Heterogenous clinical presentation of primary hyperparathyroidism in Romania
ea0063p87
A case of primary hyperparathyroidism due to a giant parathyroid adenoma extending into the mediastinum
ea0063p88
Diagnostic and treatment delay in primary hyperparathyroidism (phpt): a pending issue
ea0063p89
Epidemiology of hypoparathyroidism in Korea
ea0063p90
Effectiveness of intramuscular Ergocalciferol treatment in a patient with o steomalaciadueto severe vitamin D deficiencyafterbariatric surgery
ea0063p91
A rare case of hypercalcemia associated with dysgerminoma with elevation of 1,25(OH)2 Vitamin D
ea0063p92
Analysis of non-invasive DXA-derived bone structure parameters in patients with acromegaly with regards to vitamin D levels
ea0063p93
Osteitis Fibrosa Cystica - A Forgotten Clinical And Radiological Feature Of Primary Hyperparathyroidism
ea0063p94
Clinical use of Cinacalcet in patients with complex primary hyperparathyroidism
ea0063p95
A rare case of Graves' disease in a patient with type 1B pseudohypoparathyroidism and associated TSH resistance
ea0063p96
Primary hyperparathyroidism: clinical manifistation in Russian population
ea0063p97
The effect of vitamin D supplementation on sarcopenia indices: a systematic review and meta-analysis of randomized controlled trials
ea0063p98
The factors affecting balance function in patients with osteoporotic vertebral fractures
ea0063p99
Evaluation of trabecular bone score in men with type 1 diabetes
ea0063p100
Association between body mass index and the risk of falls: a nationwide population-based study
ea0063p101
Various clinical features of Digeorge syndrome
ea0063p102
About a case of familial hypocalciuric hypercalcemia (FHH) type 3 with neurological involvement
ea0063p103
Verified data on parathyroid hyperplasia incidence not related to primary hyperparathyroidism in persons exposed to ionizing radiation
ea0063p104
Parathyroid carcinoma: identity with diagnostic difficulties and therapeutic strategies
ea0063p105
Case Report of a large family with hyperparathyroidism- jaw tumor syndrome (HPT-JT) and a deletion of the third exon of CDC73
ea0063p106
Pseudohypoparathyroidism- a tale of hypo- and hypercalcemia with a genetic solution
ea0063p107
Generalized skeletal hyperostosis mimicking acromegaly
ea0063p108
Evaluation of bone quality in acromegaly and thyrotoxicosis using trabecular bone score
ea0063p109
Primary hyperparathyroidism and vitamin D
ea0063p110
The coincidence of primary hyperparathyroidism and primary hyperaldosteronism is not infrequent: a retrospective case analysis
ea0063p111
Bilateral hip fractures and osteoporosis in a 40-year old man - identification of a novel TMEM38 mutation causing osteogenesis imperfecta
ea0063p112
Hypomagnesemia induced disturbance of consciousness in alcoholic cirrhosis
ea0063p113
Is any body composition parameter a risk factor for symptomatic hypocalcemia after thyroidectomy?
ea0063p114
Severe diffuse tissue calcifications in a patient with pseudohypoparathyroidism type 1 A due to a novel large deletion of GNAS gene
ea0063p115
Successful removal of parathyroid cancer metastasis from VI thoracic vertebra
ea0063p116
Primary Hyperparathyroidism: about 34 observations
ea0063p117
The clinical spectrum and endocrine profile of pseudohypoparathyroidism: ACTH resistance should not be ignored
ea0063p118
Biochemical and clinical features of a family with a novel mutation of CYP24A1
ea0063p119
A case of primary hyperparathyroidism in a patient with Lobstein's disease
ea0063p120
Diabetes, Obesity and Metabolism 1
Lifestyle modification strategies to prevent diabetes in individuals who participated in a medical health check
ea0063p121
Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus
ea0063p122
Effects of lemon and cumin on premature atherosclerosis in obese patients
ea0063p123
Management of acute charcot arthropathy
ea0063p124
Non-Governmental Organizations (NGO's) & Diabetes - advocacy for support services in resource-poor nations
ea0063p125
Microvascular and macrovascular complications in a cohort of patients with type 2 diabetes mellitus
ea0063p126
Calbindin-D9k ablation cause endoplasmic reticulum stress induced [beta] cell death
ea0063p127
Serum 25-hydroxycholecalciferol and the A allele of rs2228570 of the vitamin D receptor locus reduce the risk of type 2 diabetes mellitus in Jordan
ea0063p128
Long term functional prognosis is worse in patients with chronic hyperglycemia
ea0063p129
Role of blood catecholamine in cases with dysmetablolic iron overload syndrome (DIOS) in patients of Metabolic Syndrome
ea0063p130
Incidence of obesity, overweight and hypertension in children and adolescents in Ahvaz southwest of Iran
ea0063p131
Association of serum lipid profile and insulin resistance in polycystic ovary syndrome (PCOs) women in Ahvaz, Iran
ea0063p132
A1c level in people with newly diagnosed type 2 diabetes during screening
ea0063p133
Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men
ea0063p134
The frequency of Cushing's disease, ACTH independent Cushing's syndrome, and autonomous cortisol secretion among turkish patients with obesity
ea0063p135
Higher level of astrocyte elevated gene 1 expression in peripheral blood monocytes in adults with newly diagnosed type 2
ea0063p136
The EMPA-REG OUTCOME, a real cardiovascular benefit or a play on words?
ea0063p137
Diabetic nephropathy and arterial stiffness in patients with type 1 diabetes mellitus
ea0063p138
Evaluation of perior-operational safety and efficiency of the laparoscopic gastroplication procedure compared to laparoscopic handle gasstroektomia in patients with overweight and metabolic syndrome
ea0063p139
Predictors of incident hypertension in healthy, non-diabetic postmenopausal women with normal renal function
ea0063p140
The role of sodium glucose co-transporter inhibitors in patients with acromegaly and diabetes: is there an additive effect beyond glucose control? A clinical hypothesis
ea0063p141
Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications
ea0063p142
Clinical importance of determination of glytoxic methylglyoxal in nafld and type 2 type
ea0063p143
The psychometric adaptation of the Russian version of the Diabetes Eating Problem Survey-Revised (DEPS-R)
ea0063p144
Retinol binding protein 4-marker insulin resistance in patients with diabetes mellitus 2 types and NAFLD
ea0063p145
Metabolic profile and diabetes in prison
ea0063p146
The treatment of fertile age women with obesity
ea0063p147
Prevalence and risk factors of hepatic steatosis among patients with chronic hepatitis B
ea0063p148
Negative regulation of AMPK-related kinase MPK38/MELK activity by protein phosphatase 5 (PP5)
ea0063p149
Effects of diabetes mellitus and autoimmune thyroiditis on features of rheumatoid arthritis
ea0063p150
'Killing two birds with one stone' treating porphyria patient with diabetes with SGLT2 inhibitors - a case report
ea0063p151
Effect of glucocorticoid on agouti-related protein deficient mice
ea0063p152
Insulin content and activity of inflammatory markers in patients with nonalcoholic fatial liver disease and diabetes of the second type
ea0063p153
The role of bile acids in the pathogenesis of NAFLD
ea0063p154
Improvement of human pancreatic islet quality after co-culture with human adipose-derived stem cells
ea0063p155
The association between lipoprotein (a) and metabolic syndrome
ea0063p156
Relationship study between blood groups, rhesus factor and the risk of diabetes type 2 in a population of the Sidi Othmane district, Casablanca
ea0063p157
Case-control study on the obesity prevalence in a population of diabetic's consultant at the health department of Sidi-Othmane district, Casablanca: Morocco
ea0063p158
Vitamin D: cardiovascular risk marking? About 290 patients
ea0063p159
Complementary-alternative medicine & diabetes treatment adherence
ea0063p160
Diabetes and QOL: strategies we need to work on
ea0063p161
The relationship between glycated hemoglobin, postload blood glucose levels and non-hdl cholesterol among 75 gram oral glucose tolerance test applied women
ea0063p162
Diabetes-, sex-, and BMI specific associations of genetic variants in PRRG1 with cardiovascular surrogates in a large cohort at CV risk
ea0063p163
CGI-58 gene expression is decreased in the subcutaneous adipose tissue of patients with obesity
ea0063p164
Results at 2 years of bariatric surgery in patients with type 2 diabetes mellitus
ea0063p165
Assessment of the functional activity of neutrophilic granulocytes in patients with metabolic syndrome
ea0063p166
Hygienic-dietetic habits in a group of patients with morbid obesity waiting for bariatric surgery and in a group already intervened
ea0063p167
Challenges in managing patients with type 1 diabetes and hypersensitivity reaction to insulin
ea0063p168
Relationship between liver fibrosis and diabetes-related complications in type 2 diabetic patients
ea0063p169
Study on compositions of lipids in tissues of rats with alimentary obesity
ea0063p170
Dopamine Receptor and Dopamine Transporter in Obesity: A Meta-analysis
ea0063p171
Cerebral glucose metabolism and Cerebral blood flow in Hypothyroidism and Hyperthyroidism: An activation likelihood estimation Meta-analysis
ea0063p172
Biomarkers of myocardial fibrosis at coronary heart disease in the presence and absence of diabetes mellitus type 2
ea0063p173
Prevalence of vitamin D deficiency in a population of patients with prediabetes and type 2 diabetes mellitus
ea0063p174
Genealogical analysis in diabetes mellitus risk assessment
ea0063p175
The waist-to-hip ratio is a better obesity index than body mass index and waist circumference for screening for nonalcoholic fatty liver disease in postmenopausal women
ea0063p176
The severity of different components of metabolic syndrome in hypertensive patients depending on IRS-1 gene polymorphism
ea0063p177
The association of fibroblast growth factor 23 with other factorsof mineral and bone disorder in chronic kidney disease
ea0063p178
Delivery in the diabetic women
ea0063p179
Peripheral arterial disease in Asian Type 2 diabetes mellitus under 65 years old and its risk factors
ea0063p180
Gestational diabetes mellitus and continuous glucose monitoring: glycemic patterns and pregnancy outcomes
ea0063p181
Evaluation of leptin levels in diabetic and nondiabetic patients with increased BMI
ea0063p182
Adiponectin concentrations in type 2 diabetes mellitus patients compared with healthy controls
ea0063p183
Diagnosis of type 1 DM in a patient with Hydroxymethylglutaric aciduria: Case report
ea0063p184
Novel clusters of adult-onset Diabetes: Casuistic from an Endocrinology Department
ea0063p185
Relationship between cortisoluria and the presence of metabolic syndrome among HIV-infected patients
ea0063p186
Complication of bariatric surgery as a reason of unsuccessful hypothyroidism and hypoparathyrosis treatment
ea0063p187
Assessment of asymptomatic coronary aretry disease using myocardial perfusion scan in diabetic patients
ea0063p188
HbA1c as a marker of glycemic control in patients with thalessemia HbH disease
ea0063p189
HbA1C as a marker of retrograde glycemic control in diabetes patient with co-existed beta thalassemia: Case report
ea0063p190
Clinical determinants of mean platelet volume in patients with abdominal obesity from different age groups
ea0063p191
Large phenotypic variability of diabetes due to ABCC8 gene mutation illustrated by the paradigm of a family
ea0063p192
Find prevalence of type 2 diabetes mellitus (DM) in age, BMI, symptoms and comorbidities (hypertension, dyslipidimia) in Indian scenario
ea0063p193
Clinical case of insulin autoimmune syndrome
ea0063p194
Evaluation of distance learning activities for healthcare professionals in diabetes management in Albania
ea0063p195
Type 1 diabetic patients with more than five years of disease have increased global methylation levels
ea0063p196
Results of application intensive weight management program in overweight (obese) patients with type 2 diabetes in real clinical practice
ea0063p197
Structural changes of bone tissue in patients with type 1 diabetes mellitus
ea0063p198
Early morphofunctional changes in the myocardium in young people with type 1 diabetes can be detected by magnetic resonance imaging
ea0063p199
PCSK9 inhibitors effects after 2 years in real life
ea0063p200
Acquired generalized lipodystrophy: a new cause of Anti-PD-1 immune-related diabetes
ea0063p201
Necrotizing external otitis: a severe form of otitis in diabetic patients
ea0063p202
Does osteocalcin have a role in Turkish gestational diabetes mellitus and its subgroups
ea0063p203
False memory is very common by elderly diabetics and could be a big problem in patients education and diabetes outcome
ea0063p204
GLP-1 secretion after oral glucose load is greater as eGFR is lower
ea0063p205
Lessons from studying the characteristics of type 1 diabetes mellitus patients in a tertiary hospital in Singapore
ea0063p206
An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany
ea0063p207
Lipoprotein apheresis during pregnancy in severe familial hypercholesterolemia - How and when should we switch treatment in the era of PCSK9 monoclonal antibodies?
ea0063p208
Insulin sensitivity and counter regulatory responses following hypoglycemia in healthy and type 1 diabetes patients
ea0063p209
Cardiovascular complications in metabolic syndrome in the Chernobyl NPP accident clean-up workers of in a late period upon exposure to ionizing radiation
ea0063p210
Pattern of C-peptide response to oral glucose tolerance test: interest and reference values
ea0063p211
Microalbuminuria and its relation to other factors of cardiovascular risk in type 2 diabetic patients
ea0063p212
Pecularites of psychoemotional state at diabetes mellitus
ea0063p213
Peroxisome proliferator activated receptor gamma mutation responsible for partial lipodystrophy with end stage renal disease: pharmacokinetics of metreleptine during hemodialysis: Clinical case report
ea0063p214
Lipodistrophy, a rare disease: 'If you don't think about it, you doesn't diagnose it'
ea0063p215
Please Don't Sugarcoat it: An avoidable case of Euglycaemic DKA in the setting of a SGLT-2 Inhibitor
ea0063p216
Metabolic health is strongly predicted by free Testosterone and SHBG levels in non-obese postmenopausal women
ea0063p217
The presence of polymorphic variant A1298C of the MTHFR (methylenetetrahydrofolate reductase) gene is associated with lower body mass index in girls with anorexia nervosa
ea0063p218
The inverted U-shaped curvilinear effect of fat mass on bone mineral density in Korean adolescent teenagers
ea0063p219
The effect of dapagliflozin add on to triple combination therapy in Type 2 diabetes
ea0063p220
The correlation between overweight and beta-cell function in a healthy young population: a cross-sectional study in Korea
ea0063p221
Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin: biochemical assessment in a series of 106 patients
ea0063p222
The association between serum cystatin C and carotid artery intima-media thickness in Korean type 2 diabetic patients
ea0063p223
Prevalence of psychiatric comorbidities in diabetic patients who are candidates for therapy with SGLT2 inhibitors: clinical and metabolic characteristics
ea0063p224
Pituitary and Neuroendocrinology 1
Efficacy and safety of multimodal therapy in the management of aggresive prolactinoma
ea0063p225
Metabolic fingerprint of acromegaly and its potential usefulness in clinical practice
ea0063p226
NCKX3 knockout mice showed abnormal motor function and social behavior
ea0063p227
Long terms effects of cranial irradiation for nasopharyngeal carcinoma on hypothalamic-pituitary function - a 5-years longitudinal study
ea0063p228
A rare case of recurrent granulomatous hypophysitis treated with a trial of oral glucocorticoids
ea0063p229
The role of interleukin-1 in the dynamics of exercise-induced copeptin
ea0063p230
Growth hormone deficiency, which etiologies?
ea0063p231
Mammosomatotropic adenoma and acromegaly: about 3 cases
ea0063p232
Silent somatotropic adenoma: about a case
ea0063p233
Posterior pituitary spindle-cell oncocytoma: case presentation and literature review
ea0063p234
No central adrenal insufficiency found in adults with prader-willi syndrome tested by multiple dose metyrapone test
ea0063p235
Serum aryl hydrocarbon receptor-interacting protein (AIP) levels are independent of serum GH levels both at baseline and in dynamic tests of GH stimulation and suppression
ea0063p236
Some risk factors of re-growth of non-functional pituitary adenomas in patients with growth hormone deficiency
ea0063p237
The frequency of growth retardation among children and adolescents from orphanages in Tashkent city
ea0063p238
Supraselar tumor as cause of amaurosis - the unusual suspects-case series
ea0063p239
Pituitary stalk interruption syndrome: an uncommon presentation
ea0063p240
Long-term results of bilateral adrenalectomy in a patient with cyclic Cushing's syndrome
ea0063p241
Pituitary tumors diagnosed in octogenarians - clinical implications
ea0063p242
Papillary thyroid carcinoma in acromegalic patient diagnosed with McCune Albright syndrome (MAS)
ea0063p243
Effects of octreotide on hallmarks of autophagy and on parameters related to cell viability and metabolic activity in rat pituitary tumor cells
ea0063p244
Effects of body mass index and estimated glomerular filtration rate on pituitary function in patients with non-functioning pituitary tumor
ea0063p245
Salivary carcinoma of the pituitary gland: an exceptional localization never described
ea0063p246
MRI follow-up is not useful in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogs (SMSa)
ea0063p247
Study of relationship between levels of kisspeptin and neurokinin B and markers of calcium-phosphate metabolism and water-electrolyte balance in patients with neuroendocrine disorders
ea0063p248
Spontaneous pregnancy obtained in persistent Cushing Disease treated with Cabergoline: Report of two cases
ea0063p249
Genetic study of AHR exonic part and GNAS intronic part mutations in some of Iraqi acromegalic patients
ea0063p250
Primary infundibulohypophysitis in a young man with DI and Hypogonadism
ea0063p251
A case of 'micromegaly': need for revision of oral glucose tolerance test (OGTT) cut-offs with modern growth hormone assays in acromegaly
ea0063p252
What patients with acromegaly have to say about their diagnostic pathway: A qualitative study
ea0063p253
IgG4-releated hypophysitis: A case report
ea0063p254
Trunk fat increase is prevented both in patients undergoing long-lasting continuous r-hGH therapy and in those who discontinued r-hGH compared to untreated patients: results from baseline data of the MAGHD study
ea0063p255
Hyperglycemia and pasireotide lar in acromegaly: a study with continuous glucose monitoring
ea0063p256
Radiation therapy in patients with pituitary somatotropinomas
ea0063p257
Anterior pituitary insufficiency in clinically non-functioning pituitary microadenoma
ea0063p258
Neural network for predicting recurrence of the Cushing's disease within three years after neurosurgical treatment
ea0063p259
Hyperglycemia in patients with acromegaly treated with pasireotide LAR
ea0063p260
Novel insight into ACTH-secreting pituitary tumors biological behavior: somatostatin receptor type 5 (SST5) modulation by ubiquitin specific peptidase 8 (USP8)
ea0063p261
Rare lesions of sellar, parasellar and suprasellar pathologies
ea0063p262
Baseline characteristics of adult patients with growth hormone deficiency (GHD) enrolled in NordiNet® International Outcome Study (IOS): are there variations between countries?
ea0063p263
[beta]-arrestin 2 expression is required for dopamine receptor type 2 (DRD2) inhibitory effects on Akt phosphorylation and cell proliferation in PRL-secreting and non functioning pituitary tumors
ea0063p264
Somatostatin receptor type 2 trafficking through the cytoskeleton: role of scaffolding proteins Filamin A and [beta]-arrestin 2
ea0063p265
Antitumor effects of growth hormone-releasing hormone (GHRH) antagonists in ACTH and GH-secreting pituitary adenoma cell lines
ea0063p266
Somatostatin receptor type 5 modulation by Filamin A in ACTH-secreting pituitary tumors
ea0063p267
The PATRO adults study of Omnitrope® for the treatment of adult patients with growth hormone deficiency: latest safety results
ea0063p268
Diabetes insipidus and diabetes mellitus type 2 diagnosed at the same time in a male with langerhans cell histiocytosis
ea0063p269
Assessment of endocrine function before and after transsphenoidal surgery for Cushing s disease
ea0063p270
Diverticular perforation of colon: a dangerous complication in Cushing's disease
ea0063p271
A retrospective study of 275 cases of pituitary intervention in south great plain region of Hungary
ea0063p272
Differences of efficiency of treatment of isolated growth hormone deficiency and panhypopituitarism in children in real clinical practice
ea0063p273
Functioning gonadotroph adenoma in a 46 years old male
ea0063p274
Acromegaly: ominous cause of hirsutism
ea0063p275
Pituitary apoplexy: clinical features, management and outcomes
ea0063p276
Gross total versus incomplete resection of craniopharyngioma in adults
ea0063p277
When a rare syndrome keeps behaving in rarer manners over and over again!
ea0063p278
Ipilumumab induced hypophysitis
ea0063p279
Acute lethargy, the main symptom of macroprolactinoma
ea0063p280
Pituitary apoplexy: which treatment?
ea0063p281
Cushing disease: Clinical presentation
ea0063p282
The Importance of AGR2 Expression in Pituitary Adenoma Tissue Specimens on Tumor Aggressivity
ea0063p283
The assessment of octreotide suppression test, ihc- and mr-structure, mr-signal of gh-producing pituitary adenoma for determining the prognosis of disease and management.
ea0063p284
Precocious puberty in girls in Qazvin, Iran from 2006-2018
ea0063p285
Spinal Epidural Lipomatosis: A rare complication of Cushing's disease
ea0063p286
Diagnostic tests in Cushing's disease
ea0063p287
Efficacy and safety of dopamine agonists in psychiatric patients treated with antipsychotics and presenting a macroprolactinoma
ea0063p288
Imaging features of children with growth hormone deficiency
ea0063p289
The polyuria-polydipsia syndrome: clinical and etiological profiles
ea0063p290
Syndromic growth retardation: etiological aspects
ea0063p291
GH deficiency and congenital malformation of the hypothalamic-pituitary axis: experience of the Endocrinology-diabetology Department of the Mohammed VI University Hospital Center of Oujda, Morocco
ea0063p292
Long-term effects of GH replacement therapy on thyroid function in children with GH deficiency
ea0063p293
Menstrual dysfunction (MD) with ACTH dependent Cushing syndrome
ea0063p294
Silent, isolated ACTH-deficiency in melanoma patients treated with immune checkpoint inhibitors
ea0063p295
A Case of Granulomatous Hypophysitis Mimicking Pituitary Macroadenoma
ea0063p296
Reproductive Endocrinology 1
The natural course of normal weight women with polycystic ovary syndrome: an insight into metabolic changes of a large Caucasian cohort
ea0063p297
Inhibin-B and FSH are the best predictors of spermatogenesis
ea0063p298
High prevalence of psychopathologies among transgender patients presenting at a large tertiary center: implication for the treating clinicians
ea0063p299
Bardet-Biedl syndrome in two siblings: a rare entity
ea0063p300
After up to 11 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (January 2019)
ea0063p301
Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: Study during up to 11 years on hypogonadic patients. (January 2019)
ea0063p302
Evidence for preserved ovarian reserve in transgender men receiving testosterone therapy: Anti-mullerian hormone serum levels decrease modestly after one year of treatment
ea0063p303
Female infertility: etiological factors and management
ea0063p304
Assessement of frequency of depression in women of reproductive age with polycystic ovarian syndrome
ea0063p305
A rare cause of the hypergonadotropic hypogonadism: GAPO sydrome
ea0063p306
Menstrual disorders in patients with different etiology of hyperprolactinemia
ea0063p307
Reproductive phenotype in 265 men with congenital hypogonadotropic hypogonadism and 531 men with acquired hypogonadotropic hypogonadism: a monocentric comparative study
ea0063p308
Ano-genital distance in children born of mothers with polycystic ovary syndrome - Odense Child Cohort
ea0063p309
Diagnosis and management of severe hyperandrogenism in the context of tumoral suspicion: case-series report from a tertiary hospital
ea0063p310
Ovarian reserve and exposure to environmental pollutants (ORExPo study)
ea0063p311
Normosmic hypogonadotropic hypogonadism associated with a novel TACR3 mutation
ea0063p312
A novel rare case of normosmic congenital hypogonadotropic hypogonadism associating a GnRHR and a KISS1R variants
ea0063p313
Azoospermia revealing the uncommon Jacob's syndrome
ea0063p314
Pituitary tumor as a cause of male infertility
ea0063p315
The differences in steroid hormones levels in the peripartum period caused by fetal sex and delivery type
ea0063p316
Characterization of the expression and physiological roles of thyroid-stimulating hormone receptor in the male testis
ea0063p317
Semen quality in uncontrolled acromegalic patients with hypogonadism
ea0063p318
Characteristics, geographical distribution and age at diagnosis of patients with Klinefelter syndrome in Italy: a cohort study from the Klinefelter Italian Group (KING)
ea0063p319
Gonadal Function in Human Immunodeficiency Virus (HIV)-Infected Men: comparison between Isotopic Dilution-Liquid Chromatography-Tandem Mass Spectrometry (ID-LC-MS/MS) and Chemiluminescent Immunoassay (CI)
ea0063p320
Automated free testosterone assay: validation and usual values
ea0063p321
Assessment of biochemical hyperandrogenism in PCOs by liquid chromatography tandem mass spectrometry using a multisteroid kit: focus on testosterone and androstenedione
ea0063p322
Effects of fludioxonil on cardiac differentiation of mouse embryonic stem cells
ea0063p323
Monitoring testosterone gel administration: timing and dosage
ea0063p324
Menstrual cycle characteristics in women with premature ovarian insufficiency
ea0063p325
Endocrine and menstrual disorders in adolescent girls: clinical parallels
ea0063p326
Effects of percutaneous treatment of left varicocele on spermatogenetic and endocrine function of the testis: results from a 12-month follow-up
ea0063p327
Predictive factors of polycystic ovary syndrome in women with morbid obesity
ea0063p328
Randomised Controlled Trials in women with polycystic ovary syndrome do not represent the majority of patients who are in a primary care setting: systematic review and meta-analysis
ea0063p329
The awareness of the side effects of the use of AAS as a factor of the conscious rejection of their use: The price of a beautiful body
ea0063p330
Fenhexamid increased the cell viability and metastasis of breast cancer cells via an estrogen receptor-dependent and PI3K/AKT pathway
ea0063p331
Natural estradiol in combined oral contraceptive has a favorable inflammation and lipid profile compared with preparation containing ethinyl estradiol- a randomized controlled trial
ea0063p332
Modes and actions of inter-individual transfer of estradiol and progesterone among conspecifics in both mice and bats
ea0063p333
Definition of hormonal cut-off values for discriminating polycystic ovary syndrome from non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
ea0063p334
Lipid parameters during pregnancy
ea0063p335
Dysmenorrhea prevalence and its impact on daily functioning of university nursing students in greece
ea0063p336
Thyroid 1
The serum thyroglobulin level after discontinuation of two weeks of thyroid hormone in patients with differentiated thyroid cancer can be used to determine the therapeutic dose of radioiodine
ea0063p337
Thyroid-associated orbitopathy and quality of life: correlation of GO-QoL with clinical activity score and severity in 101 patients
ea0063p338
The influence of thyroid gland subclinical form on hypercholesterolemia patients in Latvia
ea0063p339
Endocrinopathies post Immune check point inhibitors
ea0063p340
Hashimotos encephalopathy in Graves' disease
ea0063p341
Role of lipid peroxidation in the progression of autoimmune thyroiditis
ea0063p342
Clinical evaluation of TSH-receptor antibody measured by a third generation fully automated electrochemiluminescence immunoassay method in Turkish patients with Graves' disease
ea0063p343
Association between hypothyroidism and venous thromboembolism and the effect of levothyroxine in the adult: a nationwide Cohort study
ea0063p344
Should narrower TSH and free thyroid hormone levels be targeted to reduce the cardiovascular risk of euthyroid subjects?
ea0063p345
Thyroid dysfunction in Egyptian HCV patients: prevalence and possible triggering factors
ea0063p346
Management of refractory hypothyroidism with intramuscular levothyroxine: a clinical case
ea0063p347
Thyroid angiosarcoma: in the light of a case
ea0063p348
Collision tumor: A case report of tall cell variant of papillary thyroid carcinoma and laryngeal squamous cell carcinoma
ea0063p349
Outcomes of surgery and radioiodine treatment for neck recurrence in papillary thyroid cancer
ea0063p350
Anaplastic thyroid carcinoma or radiation-induced sarcoma: About a case
ea0063p351
The relationship between thyroid receptor antibody and anti mullerian hormone in Graves' disease
ea0063p352
Infrared thermography in association with indirect calorimetry: a new methodology for diagnosis and follow-up of subclinical hypothyroidism
ea0063p353
How much the implementation of an expert surgical team can improve the incidence of postoperative hypoparathyroidism
ea0063p354
An ununsual thyroid cause for Pyrexia of unknown origin (PUO)
ea0063p355
Relationship among T- and B-lymphocytes of the peripheral blood and thyroid tissue in patients with Graves' disease
ea0063p356
Association between vitamin D receptor gene polymorphisms and Graves' disease: a systematic review and meta-analysis
ea0063p357
Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis: diagnostic and therapeutic modalities
ea0063p358
A rare cause of goiter
ea0063p359
Changing practice in the management of differentiated thyroid carcinoma - experience at Brugmann Hospital in Brussels
ea0063p360
Intraoperative Neuromonitoring of the laryngeal nerves in thyroid surgery
ea0063p361
Weekly dose of L-thyroxine as a first line treatment for hypothyroidism in young and middle aged working females
ea0063p362
Analysis of clinical and biological predictors of malignancy in thyroid nodules
ea0063p363
Sensitivity and specificity of ultrasound features in predicting malignant thyroid nodules
ea0063p364
Comparison of G-CSF and non-G-CSF treatment of agranulocytosis in patients with hyperthyroidism: a meta-analysis
ea0063p365
Ocular cavity metastasis from poorly differentiated thyroid carcinoma
ea0063p366
Giant cystic pheochromocytoma: A clinically silent entity
ea0063p367
Glucocorticoid Functional Reserve in Hashimoto Hypothyroidism before and after LT4 replacement
ea0063p368
Impact of thyroid autoimmunity on obstetric and perinatal outcomes in pregnant women with subclinical hypothyroidism
ea0063p369
Abstract unavailable
ea0063p370
Navigating thyroid storm: The role of plasmapheresis in a patient also needing urgent aortic valve replacement surgery
ea0063p371
Prognostic factors for lymph node metastases in patients with papillary thyroid microcarcinoma
ea0063p372
Histological characteristics in thyroid carcinoma: our experience in the last fifteen years
ea0063p373
Impact of total thyroidectomy on quality of life: the prospective ThyrQoL multicenter trial
ea0063p374
Can urinary iodine be used in the diagnosis and follow up of subacute thyroiditis?
ea0063p375
Comparative analysis of Hashimoto's and Riedel's thyroiditis morphology and immunohistochemistry
ea0063p376
Is total thyroidectomy and bilateral central lymph node dissection essential for patients with unilateral cN1a papillary thyroid carcinoma?
ea0063p377
Should the dose of levothyroxine be changed in hypothyroidism patients fasting during Ramadan?
ea0063p378
Iodine status of schoolchildren of Belarus in 2017-2018
ea0063p379
The Effect of Ramadan fasting on thyroid hormone levels in patients on levothyroxine treatment
ea0063p380
Switch from tablet to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia in thyroxine-replaced postmenopausal women under simultaneous calcium supplementation.